Quantcast

Latest Phenylephrine Stories

2014-08-20 16:22:12

DUBLIN, Aug. 20, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Market Report of Phenylephrine" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Global Market Report of Phenylephrine (CAS 59-42-7) aims at providing comprehensive data on Phenylephrine globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Phenylephrine market trends, pays close attention to Phenylephrine This report...

2014-08-08 08:25:41

SEATTLE, Aug. 8, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference in New York next week. The presentation is scheduled for Tuesday,...

2014-07-08 08:31:53

DUBLIN, July 8, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil(®) Congestion Relief Tablets, 200 mg/10 mg. Perrigo expects to begin shipments of the product prior to the upcoming cough/cold/flu season....

2014-06-04 12:30:20

PORTLAND, Ore., June 4, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler. "Paragon is committed to working proactively with the FDA in an effort to prevent disrupting...

2014-04-09 08:28:45

PORTLAND, Ore., April 9, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%, to dilate the pupil on March 21, 2013. There is no longer a need to continue using unapproved versions of Phenylephrine Hydrochloride Ophthalmic Solution, as Paragon BioTeck's FDA approved Phenylephrine...

2013-07-25 23:00:50

Pregnant women who use nasal decongestants during the first trimester may be raising the risk that their newborn will suffer from one or more rare birth defects, according to a Reuters report about a new study. National law firm Parker Waichman LLP is now evaluating legal claims. New York, New York (PRWEB) July 25, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that women who use nasal decongestants during the...

2010-11-25 00:00:46

Although most consumers turn to the same over-the-counter medicines for winter colds, Buster Brands is ensuring that a change is in the works. Launching its "Send Us Your Nasal Spray" campaign, Buster Brands will be giving a free bottle of Sinus Buster or Allergy Buster to consumers that send in their old nasal spray. Morristown, NJ (Vocus/PRWEB) November 23, 2010 When fall and winter colds arrive, many consumers turn to the same over-the-counter medicines that they've been using for years,...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.